United Kingdom Community Advisory Board
![]()
Introduction to meeting and speakers
Reading Material
Agenda for the meeting
Report frome the meeting
![]()
Dr Ranjababu Kulasegaram Guy’s & St Thomas’ Hospital
HIV and hepatitis C co-infection
Dr Ranjababu Kulasegaram
(Babu) Dr Ranjababu Kulasegaram started specialising in GU/HIV medicine after
his general medical training and has been working at Guy's and St Thomas' Hospital
since 1995. His special interest is in managing patients with treatment difficulties,
coinfection with hepatitis C and B and in patient care.
Paul Bateman
Living with multiple conditions
Living outside London, having three medical conditions, visiting three departments in two hospitals and deciding whether to take hep C treatment!
Robert James
Personal experience of 48 weeks of interferon and ribavirin
A year in the life of Rob, weekly interferon injections, coping with side-effects, complications with HIV medication, abstaining from alcohol. Was it worth it?
![]()
In preparation for the next CAB you will need to have internet access for about 30 minutes and preferably access to a printer, and about 30 minutes to look over the material.
If you have any problems you can email Paul Foster or myself or you can call the office between 10-12am any morning next week and we'll try to give give very limited IT support.
![]()
| 9.15 - 10.30 | Women and HIV | why gender is a real issue - feedback from two recent meetings in the US by Polly Clayden. |
| 10.30 - 11.00 | Internal UK-CAB and feedback and Roche pre-meeting | |
| 11.00 - 11.30 | Break | |
| 11.30 - 12.20 | HIV and hepatitis c co-infection | Dr Ranjababu Kulasegaram (Babu) Dr Ranjababu Kulasegaram started specialising in GU/HIV medicine after his general medical training and has been working at Guy's and St Thomas' Hospital since 1995. His special interest is in managing patients with treatment difficulties, coinfection with hepatitis C and B and in patient care. |
| 12.20 - 12.35 | Living with multiple conditions | Paul, Living outside London, having three medical conditions, visiting three departments in two hospitals and deciding whether to take hep C treatment! |
| 12.35 - 12.50 | 48 weeks of interferon and ribavirin | Robert James A year in the life of Rob, weekly interferon injections, coping with side-effects, complications with HIV medication, abstaining from alcohol. Was it worth it? |
| 12.50 - 1.00 | Questions for all three speakers | |
| 1.00 - 2.00 | Lunch | |
| 2.00 - 3.30 | Roche HCV department | Dr Colin Hayward |
| Proposed agenda | ||
i) introductions ii) introduction to Roche approach to HCV products iii) trials results, by genotype, time on treatment etc iv) management of side effects v) pricing and access issues vi) future developments (treatment and monitoring) |
||